No abandonment of drug price reviews in FTA negotiation.

Published: 2006-04-18 06:58:00

Updated: 2006-04-18 06:58:00

Rep. Kim Seon-mi, a member of the National Assembly Health and Welfare Committee, raised a hard question in the parliamentary inquiry to the government administrations on April 13 especially against the descriptions disclosed in the U. S. CSR report covering that the Korean government gave up th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK